NYSE:KEYS - Keysight Stock Price, Price Target & More

Keysight trades on the New York Stock Exchange (NYSE) under the ticker symbol "KEYS."

Keysight declared that its board has approved a stock repurchase program on Wednesday, March 7th 2018, which authorizes the company to repurchase $350,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's board believes its shares are undervalued.

Keysight (NYSE:KEYS) posted its earnings results on Thursday, March, 1st. The scientific and technical instruments company reported $0.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.32 by $0.19. The scientific and technical instruments company had revenue of $837 million for the quarter, compared to analyst estimates of $805.96 million. Keysight had a net margin of 2.64% and a return on equity of 18.19%. The business's revenue was up 15.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.57 EPS. View Keysight's Earnings History.

Keysight is scheduled to release their next quarterly earnings announcement on Wednesday, May, 30th 2018. View Earnings Estimates for Keysight.

Keysight updated its second quarter earnings guidance on Thursday, March, 1st. The company provided earnings per share guidance of $0.81 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.91. The company issued revenue guidance of $964 million, compared to the consensus revenue estimate of $970.87 million.

10 equities research analysts have issued 12-month price objectives for Keysight's shares. Their predictions range from $38.00 to $65.00. On average, they expect Keysight's stock price to reach $55.1111 in the next twelve months. View Analyst Ratings for Keysight.

Some companies that are related to Keysight include Roper Technologies (ROP), Fortive (FTV), Sensata Technologies (ST), Cognex (CGNX), MKS Instruments (MKSI), Orbotech (ORBK), Esterline (ESL), Rudolph Technologies (RTEC), Mesa Laboratories (MLAB), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), International Isotopes (INIS), Sypris Solutions (SYPR) and Elbit Vision Systems (EVSNF).

News stories about KEYS stock have been trending somewhat positive on Saturday, according to Accern Sentiment. The research group identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Keysight earned a news impact score of 0.13 on Accern's scale. They also gave news stories about the scientific and technical instruments company an impact score of 46.97 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Keysight's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.57%), American Century Companies Inc. (3.49%), JPMorgan Chase & Co. (2.83%), Victory Capital Management Inc. (2.17%), Sound Shore Management Inc. CT (1.67%) and Wedge Capital Management L L P NC (1.14%). Company insiders that own Keysight stock include Charles J Dockendorff, Ingrid A Estrada, Jay Alexander, John C Skinner, Mark Adam Wallace, Mark Pierpoint, Michael Gasparian, Neil Dougherty, Ronald S Nersesian, Satish Dhanasekaran, Soon Chai Gooi and Stephen D Williams. View Institutional Ownership Trends for Keysight.

KEYS stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., American Century Companies Inc., Sound Shore Management Inc. CT, Diamond Hill Capital Management Inc., Victory Capital Management Inc., Wedge Capital Management L L P NC, Wells Fargo & Company MN and Dimensional Fund Advisors LP. Company insiders that have sold Keysight company stock in the last year include Ingrid A Estrada, Jay Alexander, John C Skinner, Mark Adam Wallace, Mark Pierpoint, Michael Gasparian, Neil Dougherty, Ronald S Nersesian, Satish Dhanasekaran, Soon Chai Gooi and Stephen D Williams. View Insider Buying and Selling for Keysight.

KEYS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Lord Abbett & CO. LLC, Millennium Management LLC, Loomis Sayles & Co. L P, Thrivent Financial for Lutherans, Columbus Circle Investors, Allianz Asset Management GmbH and Allianz Asset Management GmbH. View Insider Buying and Selling for Keysight.

Shares of KEYS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of KEYS stock can currently be purchased for approximately $53.30.

Keysight has a market capitalization of $10.15 billion and generates $3.19 billion in revenue each year. The scientific and technical instruments company earns $102 million in net income (profit) each year or $2.23 on an earnings per share basis. Keysight employs 12,600 workers across the globe.

Keysight's mailing address is 1400 FOUNTAINGROVE PARKWAY, SANTA ROSA CA, 95403. The scientific and technical instruments company can be reached via phone at 800-829-4444 or via email at [email protected]